Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-08-28

Clinical Trial Update: Efficacy of Combined Fractional Carbon Dioxide Laser and Topical Tazarotene in the Treatment of Psoriatic Nail Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating the efficacy of combining fractional CO2 laser with topical tazarotene for nail psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TAZAROTENE (TAZAROTENE)

Snippet

Sponsor: Assiut University | Conditions: Nail Psoriasis | Phase 4 | Status: UNKNOWN